Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gemcitabine as Maintenance Treatment of Diffuse Pleural Mesothelioma: Randomized Phase II Study

NCT07411144 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.

NCT NCT07411144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07411144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gemcitabine as Maintenance Treatment of Diffuse Pleural Mesothelioma: Randomized Phase II Study
Lead sponsor
National Cancer Institute, Egypt
Phase
Phase 2
Overall status
Completed
Start date
March 15, 2020
Completion date
March 15, 2023
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse pleural mesothelioma (dpm)